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Recently, it has been shown that desmoglein, pemphigus 
foliaceus target antigen, and a 130-kD pemphigus vulgaris 
antigen belong to the cadherin family of cell adhesion mole-
cules. We tried to determine whether desmocollins 1/11, 
other cadherin-like transmembranous glycoproteins present 
in desmosomes, are also recognized by pemphigus autoanti-
bodies of the IgG class. We examined 16 pemphigus vulgaris 
sera, 15 pemphigus foliaceus sera, 15 Brazilian pemphigus 
foliaceus sera, five bullous pemphigoid sera, and 65 normal 
sera. Four (25%) pemphigus vulgaris sera, one (7%) pemphi-
gus foliaceus serum, eight (53%) Brazilian pemphigus folia-
ceus sera, and three (5%) normal sera reacted with desmocol-
lins I/ll on immunoblots of bovine desmosome preparation. 
The affinity-purified desmocollins I/ll pemphigus autoanti-
bodies were shown to bind the epidermal cell surface by 
Pemphigus is an autoimmune blistering disease that can be subdivided into two major subtypes: pemphigus vul-garis (PV) and pemphigus foliaceus (PF). Brazilian (en-demic) pemphigus foliaceus (BPF) (fogo selvagem) is considered to be a variant of pemphigus foliaceus [1] . PV 
antigen, which is defined by autoantibodies from PV patients, has 
been characterized by immunoprecipitation and immunoblotting as 
a 130-kD glycoprotein, whereas PF antigen, detected by the same 
techniques, is a 160-kD or 150-kD desmosomal glycoprotein (des-
moglein) [2,3] . Recently, it has been established that these proteins 
belong to the cadherin family of calcium-dependent cell adhesion 
molecules [4-8]. Desmocollins (DC) 1/11, a pair of 115-kD and 
107-kD proteins [9], have also been shown to be cadherin-like gly-
coproteins present in desmosomes [10-14). In our previous im-
munoblot study ofBPF, we have noticed that a considerable number 
ofBPF sera reacted with a pair ofl15-kD and 105-kD proteins [15), 
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Abbreviations: 
BP: bullous pemphigoid 
BPF: Brazilian pemphigus foliaceus 
DC: desmocollin(s) 
IF: immunofluorescence 
PF: pemphigus foliaceus 
PV: pemphigus vulgaris 
50S-PAGE: sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis 
indirect immunofluorescence. Immunoblot analysis revealed 
one pemphigus vulgaris serum, one Brazilian pemphigus fo-
liaceus serum, and one normal serum recognizing a recombi-
nant protein produced by a desmocollin eDNA clone. More-
over, immunoblot analysis of reactivity of a Brazilian 
pemphigus foliaceus serum with recombinant proteins pro-
duced by deletion mutants of the desmocollin eDNA clone 
showed that the extracellular portion of desmocollin is im-
munogenic in this pemphigus patient. 
We conclude that desmocollins I/ll are recognized by cer-
tain sera from patients with various types of pemphigus, p~­
ticularly Brazilian pemphigus foliaceus . However, the sigmf-
icance of this reactivity remains to be defined. ] Invest 
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which we later supposed were DC I/Il. Additionally, we have re-
cently shown that IgA anti-cell surface autoantibodies found in 
certain atypical cases with vesiculopustular lesions seemed to react 
with DC I/Il [16). 
Therefore, in this introductory study, we wanted to determine if 
DC I/ll are recognized by pemphigus antibodies of the IgG class 
and which portion of these molecules is immunogenic in pemphi-
gus patients. 
MATERIALS AND METHODS 
Sera We examined 16 PV, 15 PF, and 15 BPF sera. Five bullous 
pemphigoid (BP) sera containing anti-basement membrane zone 
antibodies at a titer of greater than 1 : 40 as determined by indirect 
immunofluorescence (IF), and 65 normal human sera were used as 
controls. All pemphigus sera contained anti-cell surface antibodies 
at a titer of greater than 1 : 40 as determined by indirect IF on normal 
human epidermis. None of control sera contained anti-cell surface 
antibodies. All sera were stored at - 80 0 C and briefly at 4 0 C in the 
presence of 0.1 % NaN3 during the experiments. 
Monoclonal Antibodies We used anti - DC I/Il monoclonal 
antibody (52-3D) [10) recognizing their cytoplasmic regions; anti-
desmoglein monoclonal antibody (32-2B), which recognizes its cy-
toplasmic region [17); and anti-desmoplakins l/ll monoclonal anti-
body (11-5F) [18]. 
Construction and Isolation of an Expression Clone of DC II 
eDNA, and Preparation ofits Deletion Mutants All reagents, 
except for those used in deletion experiment, were purchased from 
Toyobo Co., Osaka, Japan. DC II cDNA clone (CN35) was ob-
tained from a bovine nasal epidermal Agtl1 cDNA library [14]. To 
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produce DC II recombinant protein efficiently, 2.77-kb cDNA 
fragment (designated CN35-XbaI) was obtained by digestion of 
CN35 at XbaI restriction sites in the precursor sequence and a little 
downstream to the stop codon, and subcloned in-frame into 
pUC18. Therefore, CN35-XbaI produced r~combinant proteil~ 
containing entire mature DC II. To produce umdlrectlOnal (from 5 
end encoding extracellular amino-terminus of DC II) deletions 
(Deletion Kit for Kilosequence; Takara Biomedicals, Kyoto,Japan), 
the pUC18-CN35-Xbal was first double digested with Kpnl 
(unique 3' overhang restriction site) and BamHI (unique 5' over-
hang restriction site lying between the 5' end of CN35-Xbal msert 
and Kpnl restriction site). Then, double-digested DNA was treated 
with exonuclease III for various time intervals, followed by treat-
ment with Mung Bean nuclease, and finally ligated with T4 DNA 
ligase to recircularize. Deletion mutants of CN35-XbaI were trans-
fected into Escherichia coli strain XU-Blue. The size of inserts of 
deletion mutants of CN35-XbaI clone was determined on 0.7% 
agarose gel electrophoresis after inserts were cut out by double di-
gestion with EcoRI and Sail. . 
Production of DC II Recombinant Proteins The XU-Blue 
cells transformed with CN35-Xbal or its deletion mutants were 
cultured at 37°C for 3.5 h in LB medium and induced by an addi-
tion of 1.5 mM isopropyl P-D-thiogalactopyranoside. After 3.5 h 
further culture the cells were harvested, resuspended in 50 mM 
Tris-HCl buffer (pH 8.0) with 1 mM ethylenediaminetetraacetic 
acid, and treated with lysozyme. After the extraction with deoxy-
cholic acid and treatment with DNase I, the lysates were centn-
fuged at 13,000 X g and the pellets boiled in LaemmIi's sample 
buffer with 5% p-mercaptoethanol before being subjected to so-
dium dodecyl sulfate - polyacrylamide gel electrophoresis (SDS-
PAGE). 
Immunoblot Analysis Dermoepidermal separation with dis-
pase, extraction of normal human epidermis, an? preparation of 
bovine desmosome sample were performed accordmg to the proce-
dures described previously [3,15,19]. Dispase-treated normal 
human epidermal extract (80 J1.g protein/lane), bovine desmosome 
preparation (6 J1.g protein/lane), recombinant protein of CN35-
Xbal (RP1), and recombinant proteins of CN35-Xbal deletIOn mu-
tants (RP2-5) were run on SDS-PAGE according to Laemmli's 
method [20] using 7% separating gel (for human epidermal extract, 
bovine desmosome preparation, and RPI analysis with sera or mono-
clonal antibodies) or 10% separating gel (for RPl-5 analysis with 
BPF2 serum), and electrophoretically transferred to nitrocellulose 
membranes (Schleicher and Schuell, Dassel, Germany) [21] . For 
immunostaining, blots were first blocked with 3% skim milk in 
Tris-HCI- buffered saline (pH 8.0) and then reacted with sera di-
luted 1: 40 (in experiments with human epidermal extract and bo-
vine desmosome preparation), with sera diluted 1: 20 and preab-
sorbed with equal volume of lysate of plasmid-free XU-Blue for 
1 h at room temperature to reduce background staining (in experi-
ments with RPI-5), or with monoclonal antibodies diluted 1: 200. 
Peroxidase-conjugated anti-human IgG rabbit antiserum (DAKO) 
diluted 1 : 100 or peroxidase-conjugated rabbit anti-mouse immuno-
globulins antiserum (DAKO) diluted 1: 100 were used as a se~ond­
ary antibody. Color was developed by 4-chloro-l-naphthol m the 
presence of hydrogen peroxide. 
Affinity Purification of DC 1/ 11 IgG Affinity purification of 
DC I/ll IgG was performed mainly according to the previously 
described methods [4,22]. Briefly, horizontal strips of nitrocellulose 
containing the bovine DC I/II and control strips of equal width 
below the area where the DC I/Il were located were cut out, incu-
bated with a BPF serum or a PV serum, and washed. Bound antibod-
ies were eluted with sodium citrate buffer (pH 3.2), immediately 
neutralized, dialyzed against phosphate-buffered saline, and con-
centrated by ultrafiltration (Centriprep 10, Amicon, Danvers, MA). 
Indirect IF The concentrated eluates were used to determine 
whether the affinity-purified DC 1/11 IgG bind the epidermal cell 
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surface. Indirect IF using either normal human skin or bovine muz-
zle epidermis as a substrate and fluorescein isothiocyanate-
conjugated rabbit immunoglobulins to human IgG (DAKO, Co-
penhagen, Denmark) as a secondary antibody was performed 
according to the standard method. 
RESULTS 
Immunoblot Analysis of Human Epidermal Extract All PV 
sera recognized the 130-kD human PV antigen. Of 15 PF sera, 
seven labeled the 150-kD antigen (desmoglein) and one labeled the 
' 130-kD PV antigen. Of 15 BPF sera, seven recognized desmoglein 
and three labeled the 130-kD PV antigen. All BP sera reacted 
weakly with the 230-kD BP antigen, but failed to recognize the 
180-kD BP antigen, desmoglein, the 130-kD PV antigen, and DC 
1/11. Non~ of 65 control normal sera recognized any specific epider-
mal protems (Table I) . Although anti-DC I/II monoclonal anti-
body labeled weakly a pair of 11 O-kD and 1 OO-kD proteins (presum-
~bly human DC I/~I), this pair was not labeled by any sera, 
mcludmg those reactlllg strongly with bovine DC I/ll in desmo-
some preparation (see below). 
Immunoblot Analysis of Bovine Desmosome Preparat-
ion As shown in Table I and Fig 1, of 16 PV sera 12 labeled the 
135-kD bovine PV antigen, eight recognized desmoglein, and four 
(2?/o) detecteda pair of 115-kD and 105-kD proteins. These pro-
tems were. considered to be DC 1/11, because anti - DC I/ll mono-
clonal anttbody and 115-kD /1 05-kD protein - positive sera identi-
fied co-migrating bands. All PF sera recognized desmoglein and one 
(7%) PF serum detected DC 1/11. Of 15 BPF sera, 13 labeled des-
moglein and eight (53%) detected DC 1/11. Of 65 control normal 
sera, seven recognized desmoglein and three (5%) DC 1/11. Virtu-
ally all desmoglein- and/or DC I/ll - positive normal sera reacted 
with these proteins much more weakly than pemphigus sera did. 
None of five BP sera recognized any specific bands, including the 
230-kD and 180-kD BP antigens, desmoglein, the 135-kD bovine 
PV antigen, and DC 1/11. 
T~e Analysis .of the. Affinity-Purified DC 1/11 IgG We ob-
tamed the affilllty-punfied DC 1/11 IgG from either the BPF serum 
labeling desmoglein and DC 1/11 on immunoblots of bovine des-
mosome sampl.e or the PV serum reacting with DC I/II on immu-
noblots of bovllle desmosome preparation and the 130-kD human 
PV antigen. The affinity-purified DC 1/11 IgG from both cases 
bound DC I/II on Immunoblots of bovine desmosome sample (Fig 
2A) . Fu~thermore, the affinity-purified DC I/Il IgG from the BPF 
serum did not show th~ reactivity with desmoglein, indicating that 
DC I/ll .and de~moglelll do not share common epitopes. Control 
eluates. did not bllld any proteins on immunoblots (Fig 2A). Indirect 
IF on either normal human s.kin or bovine muzzle epidermis demon-
strated that the affimty-punfied DC 1/11 IgG prepared from either 
th~ BPF serum or the PV serum bound the epidermal cell surface 
(Fig 2B). Control eluates prepared from both sera did not show the 
epidermal cell surface staining (Fig 2C). 
Immunoblot Analysis of RPl (DC II Recombinant Protein 
Pr~duced by Undeleted 2.77-kb CN35-Xbal Clone) Only 
antt - DC 1/11 monoclonal antibody reacted with RPl, whereas cul-
ture supernatant of parental cells for hybridoma, anti-desmoglein 
monoc.lonal antibody, and anti-desmoplakins I/Il mon.oclonal anti-
body did not show any reactivity, confirming the specificity ofRP1 
(data not shown). The results ofRPl analysis with sera are shown in 
Table I and Fig 3. RP1 was recognized by one (6%) of 16 PV sera, 
one (7%) of 15 BPF sera, and one (1 %) of 65 control sera. None of 
the PF sera recognized RP1. All sera that reacted with RP1 also 
recognized bovine DC 1/11. None ofBP sera labeled RPl. None of 
the control normal sera that recognized DC r/Il in desmosome 
preparation and RP1 showed epidermal cell surface staining with 
indirect IF. 
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Table I. Reactivities of Sera in Immunoblotting of Human Epidermal Extract, Bovine Desmosome preparation, and DC II 
Recombinant Protein Produced by CN35-Xbal Clone (RPl) 
Epidermal Extract 
Sera 150 kD 130 kD hDC' 
PV (n = 16) 0 16 0 
PF (n = 15) 7 1 0 
BPF (n = 15) 7 3 0 
BP (n= 5) 0 0 0 
Control (n = 65) 0 0 0 
• A pair of 110-kD and 100-kD proteins (human DC IjIl). 
I A pair of 11S-kD and lOS-kD proteins (bovine DC Ijll). 
Immunoblot Analysis of RP2-5 (DC II Recombinant Pro-
teins Produced by Deletion Mutants of CN35-XbaI Clone) 
Four recombinant proteins produced by deletion mutants of CN35-
Xbal clone having inserts of 1.95 kb (RP2), 1.50 kb (RP3), 1.35 kb 
(RP4), and 0.85 kb (RP5) were selet:ted for analysis with BPF2 
serum, which showed the strongest reactivity with DC I/ll in bo-
vine desmosome sample and with RP1. Both anti - DC I/ll mono-
clonal antibody and BPF2 serum labeled RPl-4. Only RP5 (consid-
ered to correspond to the entire cytoplasmic region of DC II by the 
determination of the size of insert eDNA), although recognized by 
anti - DC I/ll monoclonal antibody, was not labeled by BPF2 serum 
(Fig 4). These findings suggest that epitope(s) recognized at least by 
this particular serum is (are) localized on the extracellular region of 
DC 1/11. 
DISCUSSION 
Recently, the heterogeneity of the antigen/antibody systems in-
volved in the pathogenesis of pemphigus has been suggested on the 
basis of the production ofigM class anti-185-kD protein monoclo-
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Figure 1. Immunoblot analysis of representative sera with the bovine 
desmosome preparation (DM). AB, amido black-stained lane; M, anti-
DC 111I monoclonal antibody; B, BPF serum; PV, PV serum; PF, PF serum; 
C, control normal serum. Arrowheads, from top to bottom, the positions of 
the 150-kD protein (desmoglein), the 135-kD bovine PV .antigen, and a 
pair of 115-kD and 105-kD proteins (this pair was regarded to be DC 111I 
because anti-DC IIIl monoclonal antibody and 115-kD/I05-kD 
protein-positive sera identified co-migrating bands). Bars, from top to 
bottom, the positions of molecular weight markers: 200 kD, 116 kD, 
97 kD, and 66 kD. Bl, B2, B3, and B4 sera recognized the 150-kD protein, 
whereas B2, B3, and B4 sera labeled additionally a pair of 115-kD and 
105-kD proteins. PVl, PV2, and PV3 sera recognized the 135-kD PV 
antigen. PV2 and PV3 sera reacted also with the 150-kD protein, whereas 
PV3 serum reacted additionally with a pair of 115-kD and 105-kD pro-
teins. PFl , PF2, and PF3 sera recognized the 150-kD protein. PF3 serum 
reacted also with a pair of 115-kD and 1 05-kD proteins. Cl serum labeled 
a pair of 115-kD and 105-kD proteins, whereas C2 serum did not show 
any reactivity. 
Desmosome Preparation 
150 kD 135 kD bDCb RPI 
8 12 4 (25%) 1 (6%) 
15 0 1 (7%) 0 
13 0 8 (53%) 1 (7%) 
0 0 0 0 
7 0 3 ( 5%) 1 (1%) 
nal antibody derived from a PV patient [23]. Moreover, it has been 
found that four polypeptides with molecular weights of 250 kD 
(desmoplakin I), 230 kD ("major" BP antigen), 210 kD (desmo-
plakin II), and 190 kD are immunoprecipitated by sera from pa-
tients with paraneoplastic pemphigus [24,25[, a mucocutaneous dis-
ease with some clinical features reminiscent of pemphigus. Such 
stu'dies indicate that the further search for target antigens for the 
anti-epidermal cell surface autoantibodies is required. 
In the present study, immunoblotting of bovine desmosome prep-
aration shows that certain pemphigus sera cl early react with a pair of 
115-kD and 105-kD proteins. Comparison with the reactivity of 
anti - DC I/ll monoclonal antibody indicates that these proteins 
correspond to bovine DC l/II. Furthermore, the results of our affin-
ity-purification studies indicate that DC I/ll are indeed pemphigus 
antigens because the affinity-purified DC I/II IgG stained the epi-
dermal cell surface. However, no sera examined by us showed any 
apparent reactivity with human DC I/ll on immunoblots of the 
human epidermal extract. This discrepancy may be caused by the 
existence of quantitative as well as qualitative differences in the 
expression of epidermal proteins, including DC I/ll, between 
epithelia from various species. It should be noted here that the 
usefulness of non-human epithelia for the detection of human pem-
phigus antibodies is well-established, e.g., it has been shown that 
the most sensitive substrates for the detection ofpv and PF antibod-
ies by indirect IF are monkey esophagus and guinea pig esophagus, 
respectively [26] . 
To confirm that some pemphigus sera react with DC I/lI, we 
performed immunoblot analysis of recombinant protein produced 
~ 
~ 
Figure 2. The analysis of the affinity-purified DC VII IgG. lmmunoblot 
analysis using bovine desmosome sample as an antigen source (A) . All 
abbreviations are the same as those in Fig 1. Arrowheads, from top to 
bottom, the positions of desmoglein and DC I/ll. The B2 serum reacted 
with desmoglein and DC Ijll (Ialle 1), the PV4 serum reacted with DC IIII 
(talle 4). This PV serum also recognized the 130-kD PV antigen with 
irnmunoblotting of the human epidermal extract. The affinity-purified 
DC Ill! IgG prepared from B2 serum (Ialle 2) and PV4 semm (Ialle 5) 
reacted only with DC VII. Control eluates prepared from B2 serum (talle 
3) and PV4 serum (Ialle 6) did not show any reactivity. Indirect IF on 
bovine muzzle epidermis demonstrated that affinity-purified DC 1/IlIgG 
prepared from B2 semm bound the epidermal cell surface (B), whereas 
control eluate prepared from the same serum did not bind the epidermis 
(e). Bars, 10 ).I.m. 
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Figure 3. lmmunoblot analysis of representative sera with the RPl. All 
abbreviations are the same as those in Fig l. Arrowhead, the position of 
RPI. B2, PV3 and Cl sera recognized RPl, whereas PFl, PF3, and C2 sera 
did not. Lower bands seen in lalle M were considered to be the degradation 
products of RPI. 
by cDNA clone encoding entire mature DC II. This study indica~es 
that certain pemphigus sera recognize DC II recombinant protem, 
although the frequency of this reactivity is very low. Thus, we 
hypothesize that the majority of DC 1/11 - positive sera react with 
conformation-dependent epitopes and/or sugar side chains on DC 
IjlI. On the other hand, it has been suggested that the type of 
desmosomal cadherin expressed may vary as keratinization of skm 
takes place [27]. A DC-like 46/48-kD glycoprotein from human 
skin has been detected that, although it has homology with human 
DC, in fact has more homology with bovine DC [28]. Thus, there 
may be a set of DC-like molecules, and the antigen for the ma-
jority of DC Ijll-positive sera may not be encoded by CN35 
clone. 
The reactivity of some normal control sera with DC 1/11 is puz-
zling. We hypothesize that certain normal human sera recognize 
DC-related molecules having common epitopes with typical DC. 
These epitopes may not be expressed in intact epidermis, which may 
be responsible for the lack of epidermal cell surface staining by the 
DC-positive normal human sera. Alternatively, such sera may con-
tain non-specific antibodies to carbohydrate moiety of various gly-
coproteins, including desmoglein and DC 1/11. These carbohydrate 
moiety-recognizing antibodies may bind to the desmosomal glyco-
proteins too weakly to be detected by indirect IF. . 
The low frequency of reactivity of pemphigus sera with the DC 
II recombinant protein, as well as the existence of a few DC Ijll-
positive normal sera, make the significance of anti - DC l/ll anti-
bodies in pemphigus uncertain at present. However, more than 50% 
ofBPF sera examined in this study labeled DC l/II. It is interesting 
that BPF sera reacted with DC I/ll much more frequently than 
sporadic PF sera despite the fact that both BPF and spora4ic PF sera 
examined in this study contained roughly similar high titers of 
pemphigus antibodies. This finding suggests that the reactivity of 
some BPF sera with DC is not a function of antibody titer. Thus, we 
suggest that the possible role of anti-DC 1/11 autoantibodies in the 
pathogenesis of at least BPF should be defined. 
In this study we also tried to determine which portion of DC 1/11 
is immunogenic in pemphigus patients. Our results suggest that the 
extracellular region of these molecules contains epitope(s) for cer-
tain pemphigus antibodies. The question immediately arises regard-
ing the exact nature of these epitores. It has been found [29] that the 
epitopes for antibodies capable 0 blocking cadherin action are lo-
cated in their amino-terminal 113 amino acid region. Recently, 
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Figure 4. Immunoblot analysis of the BPF serum (B2) with a set of DC II 
recombinant proteins. RPI indicates DC II recombinant protein produced 
by undeleted 2.77-kb CN35-XbaI clone. RP2-5 were produced by four 
deletion mutants of CN35-XbaI clone. The longest l.9S-kb clone encoded 
RP2, l.SO-kb clone encoded RP3, l.35-kb clone encoded RP4, and the 
shortest O.85-kb clone encoded RPS (entire cytoplasmic region of RPl). 
Lottes M, anti - DC 1/11 monoclonal antibody. Lattes B2, BPF2 serum. A rrow-
I,eads, positions of DC II recombinant proteins. Lower bands seen in lalles 
M were considered to be the degradation products of recombinant pro-
teins. Bars, from top to bottom, the positions of molecular weight markers: 
116 kD, 97 kD, 66 kD, and 43 kD. Both anti-DC VII monoclonal anti-
body and B2 serum recognized RPl-4. RPS was labeled by anti-DC 1/11 
monoclonal antibody but not by B2 serum. 
A~agai et a1J30] have demonstrated that autoantibodies against the 
amm~-termmal regIOn of the PV antigen are pathogenic. More-
over, It has been shown [31] that the epitope for monoclonal anti-
body DECMA-l, capable of blocking E-cadherin function, is lo-
cated . close to. th.e membrane-proximal part of its extracellular 
?omam. The slgl1lficant homology of DC I/ll with typical cad her-
ms J11-14,32] sugge.sts that the amino-terminus of DC l/ll and 
theIr membrane-proximal part of the extracellular domain might be 
Similarly Important for keratinocyte cell-to-cell adhesion. We sup-
pose that.some pemphigus autoantibodies might bind to epitopes on 
these reg.lOns of DC 1/11, which in turn might contribute to the loss 
of adheSIOn between keratinocytes. The direct evidence that this 
process does occur in pemphigus patients is lacking but it has been 
shown that Fab' fractions of an anti-DC antiserum inhibit desmo-
some assembly when added to the culture medium of subconfluent 
cells [33] . 
. In co~clusio.n, DC I/n are recognized by certain sera from pa-
tients with van~)Us types of pemphigus, but the significance of this 
reactivity remams to be defined. 
Finally, this study shows that certain PV sera react with both 
desmoglein and the 135-kD PV antigen on immunoblots of bovine 
desmoson:e preparation, which confirms previous data [3]. Our re-
sults also mdlcate that despite the fact that BPF and PF sera are 
consistently bovine PV antigen-negative, some of these sera may 
react with the 130-kD PV antigen on immunoblots of human epi-
dermal extracts . Nevertheless, there is a considerable difference of 
reactivity between PV and PF sera, which enables us to diagnose 
almost all pemphigus cases as PV or PF by immunoblotting. How-
ever, further immunoblot studies with the use of various antigen 
sources should be performed to unequivocally prove our previous 
suggestion [34] that the immunoblot technique can be used to distin-
guish PV and PF. 
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